Table 2.

Countries or Organizations Participating in ASIGN Development or Pilot Testing

Country or organization	Number of participarts	Educator (E), clinician (C), organization leader (OL)	Genomic expertise Yes/No	Phase 1 CSF survey Yes/No	ASIGN development participatior Yes/No	Pilot test participatior Yes/No
Australia	1	E	Yes	No	No	Yes
Brazil	1	E, C	Yes	Yes	Yes	Yes
Canada	1	E	Yes	Yes	Yes	Yes
Columbia	1	E	No	Yes	Yes	Yes
Germany	1	E	No	Yes	Yes	Yes
Hong Kong	1	E	Yes	Yes	Yes	Yes
Israel	1	E	Yes	No	Yes	Yes
Japan	1	E	Yes	Yes	Yes	Yes
Mexico	1	E	Yes	No	Yes	Yes
Netherlands	1	C	Yes	No	Yes	Yes
Norway	1	C	Yes	No	Yes	No
Nigeria	1	E	No	No	No	Yes
Pakistar	1	C	Yes	Yes	Yes	Yes
South Africa	1	E	No	No	Yes	No
Switzerland	1	E	Yes	Yes	Yes	Yes
Taiwan	1	C	Yes	Yes	Yes	Yes
Turkey	1	E	Yes	Yes	Yes	Yes
United Kingdom	5	E (n = 2) and C (n = 3)	Yes	Yes (n = 2)	Yes	Yes
United States	2	E, C	Yes	Yes (n = 1)	Yes	Yes
EBMG	1a	OL, C	Yes	No	Yes	No
GAUK	1	OL	Yes	No	Yes	No
HEE	2	OL	Yes	No	Yes	No
ICN	1	OL	Yes	No	Yes	No
ISONG	1	OL, C	Yes	Yes	Yes	No
STTI	1	OL, E	Yes	Yes	Yes	No
NHGRI	1b	C	Yes	No	Yes	No

Note. ASIGN = Assessment of Strategic Integration of Genomics across Nursing; EBMG = European Board of Medical Genetics; GAUK = Genetic Alliance UK; HEE = Health Education England; ICN = International Council for Nurses; ISONG = International Society of Nurses in Genetics; NHGRI = National Human Genome Research Institute (U.S.A.); STTI = Sigma Theta Tau International.

^aAlso represented the United Kingdom.

^bAlso represented the United States.